[O2–14–04]: AGGREGATE‐SELECTIVE ANTI‐TAU ANTIBODY MC‐1 DEMONSTRATED ROBUST IN VITRO AND IN VIVO ACTIVITY TO NEUTRALIZE TRANSMISSIBLE TAU AND REDUCE TAU PATHOLOGY. (1st July 2017)